Lifecore Biomedical, Inc.

Total Valuation

Lifecore Biomedical, Inc. carries a market capitalization of 171.79M, placing it among publicly traded companies globally. Its enterprise value stands at 385.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Lifecore Biomedical, Inc. currently has 37.47M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 1.98, and the price-to-book ratio stands at -1.23.

Enterprise Valuation

On an enterprise value basis, Lifecore Biomedical, Inc. trades at an EV/EBITDA multiple of 103.87 and an EV/FCF ratio of 10.37.

Financial Position

Lifecore Biomedical, Inc. maintains a current ratio of 2.80, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,290.22, indicating conservative leverage, while an interest coverage ratio of 0.16 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Lifecore Biomedical, Inc.'s stock has declined approximately -38.44086% over the past 52 weeks. The 50-day moving average sits at 5.06, while the 200-day moving average is 6.34.

Income Statement

Over the trailing twelve months, Lifecore Biomedical, Inc. generated 135.27M in revenue and converted that into -32.48M in net income, yielding earnings per share of -0.89. EBITDA reached 3.71M, while operating income came in at -4.30M.

Balance Sheet

Lifecore Biomedical, Inc. holds 18.86M in cash and equivalents against 135.95M in total debt, resulting in a net debt position of 117.10M. Total book value stands at -218.06M, with working capital of 53.97M providing operational flexibility.

Cash Flow

Lifecore Biomedical, Inc. produced 2.17M in operating cash flow over the past twelve months. After subtracting -11.73M in capital expenditures, free cash flow totaled -9.56M - equivalent to -0.26 per share.

Margins

Lifecore Biomedical, Inc. operates with a gross margin of 31.57, reflecting its pricing power and cost economics. The operating margin of -3.18 and net profit margin of -24.01 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 7.31 indicates the proportion of earnings distributed to shareholders.

Scores

Lifecore Biomedical, Inc. posts an Altman Z-Score of 0.10, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.